metadata toggle
Clinical particulars
Target species
Cattle
Indications for use, specifying the target species
Infections of cattle with parasites sensitive to moxidectin.
For the treatment of infections caused by:
− Adult and larval gastro-intestinal nematodes:
Haemonchus placei
Ostertagia ostertagi (including inhibited larvae)
Trichostrongylus axei
Nematodirus helvetianus
Cooperia oncophora
Cooperia punctata (adults)
Oesophagostomum radiatum (adults)
Bunostomum phlebotomum (adults)
− Adult respiratory tract nematode
Dictyocaulus viviparus
− Warbles (migrating larvae)
Hypoderma bovis
Hypoderma lineatum
− Lice
Linognathus vituli
Haematopinus eurysternus
Solenopotes capillatus
Bovicola bovis (Damalinia bovis)
− Mange Mites
Sarcoptes scabiei
Psoroptes ovis
Chorioptes bovis
- Horn Flies
Haematobia irritans
− Cydectin 0.5% w/v Pour-On for Cattle has a persistent effect in preventing against reinfection by:
Ostertagia ostertagi for 5 weeks
Dictyocaulus viviparus for 6 weeks.
Contraindications
Not to be used in other species as severe adverse reactions, including fatalities in dogs, may occur.
See Section "Withdrawal period(s)".
Special warnings for each target species
None.
Special precautions for use
Special precautions for use in animals
For topical application only.
To avoid secondary reactions due to the death of Hypoderma larvae in the oesophagus or the spine, it is recommended to administer the veterinary medicinal product at the end of the period of fly activity and before the larvae reach their resting sites: consult the veterinarian to know the correct treatment period.
Special precautions to be taken by the person administering the veterinary medicinal product to animals
- Do not smoke, eat or drink while handling the veterinary medicinal product.
− Avoid direct contact with skin and eyes.
− Wash hands after use.
− Protective clothes and gloves are recommended when using the veterinary medicinal product.
− If splashed in the eye or on the skin, wash with plenty of clean, running water immediately.
Special precautions for the protection of the environment
Moxidectin fulfils the criteria for a (very) persistent, bioaccumulative and toxic (PBT) substance; therefore, exposure of the environment to moxidectin must be limited to the extent possible. Treatments should be administered only when necessary and should be based on faecal egg counts or evaluation of the risk of infestation at the animal and/or herd level.
Like other macrocyclic lactones, moxidectin has the potential to adversely affect non-target organisms:
∙ Faeces containing moxidectin excreted onto pasture by treated animals may temporarily reduce the abundance of dung feeding organisms. Following treatment of cattle with the veterinary medicinal product, levels of moxidectin that are potentially toxic to dung fly species may be excreted over a period more than 2 weeks and may decrease dung fly abundance during that period. It has been established in laboratory tests that moxidectin may temporarily affect dung beetle reproduction; however, field studies indicate no-long term effects. Nevertheless, in case of repeated treatments with moxidectin (as with veterinary medicinal products of the same anthelmintic class) it is advisable not to treat animals every time on the same pasture to allow dung fauna populations to recover.
∙ Moxidectin is inherently toxic to aquatic organisms including fish. The veterinary medicinal product should be used only according to the label instructions. Based on the excretion profile of moxidectin when administered as the pour-on formulation, treated animals should not have access to watercourses during the first week after treatment.
Other precautions
Not applicable.
Adverse reactions (frequency and seriousness)
Cattle
Very rare
(<1 animal / 10,000 animals treated, including isolated reports):
Application site reaction
Neurological signs (such as ataxia and trembling)
Lethargy
Reporting adverse events is important. It allows continuous safety monitoring of a veterinary medicinal product. Reports should be sent, preferably via a veterinarian, to either the marketing authorisation holder or the national competent authority via the national reporting system. See the package leaflet for respective contact details.
Use during pregnancy, lactation or lay
The safety of moxidectin was established during pregnancy, lactation and in breeding bulls.
See Section "Withdrawal period(s)".
Interaction with other medicinal products and other forms of interaction
None known.
Amount(s) to be administered and administration route
Pour on use.
500 µg moxidectin/kg body weight (1 ml for 10 kg) as a single topical application.
To be administered along the midline of the back of the animal from the withers to the tailhead.
Apply to clean healthy skin.
Overdose (symptoms, emergency procedures, antidotes), if necessary
No symptoms of overdose have been observed with the veterinary medicinal product given at ten times the recommended dose.
They are manifested as transient salivation, depression, drowsiness and ataxia. There is no specific antidote.
Withdrawal period(s)
Meat and offal: 14 days.
Milk: 6 days (144 hours).